Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Redefining Self: Patients' Decision Making About Treatment for Multiple Sclerosis.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
MRI pattern in asymptomatic natalizumab-associated PML.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
Vitamin D as a protective factor in multiple sclerosis.
Neuropathic pain: diagnosis and treatment.
[Neuroimmunology: theoretical and clinical aspects].
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Microwave & magnetic (M(2) ) proteomics of the EAE animal model of multiple sclerosis.
Additive effect of prostaglandin E(2) and adenosine in mouse experimental autoimmune encephalomyelitis.
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica.
Dysfunction in Motor Coordination in Neonatal White Matter Injury Model without Apparent Neuron Loss.
Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis.
The evolution of vertebrate and invertebrate myelin: a theoretical computational study.
Secondary Health Conditions in Individuals With Multiple Sclerosis: A Cross-Sectional Web-Based Survey Analysis.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
Mood and coping in clinically isolated syndrome and multiple sclerosis.
Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo.
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
Dual task cost of cognition is related to fall risk in patients with multiple sclerosis: A prospective study.
The effect of rhythmic-cued motor imagery on walking, fatigue and quality of life in people with multiple sclerosis: A randomised controlled trial.
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »